vilaprisan and Renal-Insufficiency

vilaprisan has been researched along with Renal-Insufficiency* in 1 studies

Trials

1 trial(s) available for vilaprisan and Renal-Insufficiency

Article	Year
Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment. Journal of clinical pharmacology, 2020, Volume: 60, Issue:8 This open label, parallel-group study investigated the pharmacokinetics and safety of a single oral 2-mg dose of the novel selective progesterone receptor modulator vilaprisan in participants with impaired renal function compared with age, weight, sex, and race matched controls with normal renal function. Systemic exposure (area under the plasma concentration-time curve [AUC]) and maximum observed concentrations (C Topics: Administration, Oral; Adult; Aged; Area Under Curve; Drug Evaluation; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Receptors, Progesterone; Renal Insufficiency; Steroids	2020

Article

Year

Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment.

Journal of clinical pharmacology, 2020, Volume: 60, Issue:8

This open label, parallel-group study investigated the pharmacokinetics and safety of a single oral 2-mg dose of the novel selective progesterone receptor modulator vilaprisan in participants with impaired renal function compared with age, weight, sex, and race matched controls with normal renal function. Systemic exposure (area under the plasma concentration-time curve [AUC]) and maximum observed concentrations (C

Topics: Administration, Oral; Adult; Aged; Area Under Curve; Drug Evaluation; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Receptors, Progesterone; Renal Insufficiency; Steroids

2020